Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-21

FDA Approved: LAMIVUDINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original ANDA for lamivudine, enabling a generic version of lamivudine to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)